Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02688660 · ClinicalTrials.gov registry record
MRI Markers of Outcome After Severe Pediatric TBI
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 82
- Enrollment target
NCT02688660: Completed study, sponsored by University of Wisconsin, Madison.
NCT02688660 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 82 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02688660 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
Traumatic brain injury (TBI) is the leading cause of death or disability in children. Each year in the United States, pediatric TBI results in an estimated 630,000 emergency room visits, 58,900 hospitalizations, and 7000 deaths. The incidence of long-term disability after severe TBI is high, with over 60% of children requiring educational or community based supportive services 12 months post-injury. Over 5,000 children require inpatient rehabilitation after TBI each year and an estimated 145,000 US children are currently living with disabilities after a severe TBI. Hospital costs for the acute treatment of children with TBI are estimated at \~$2.6 billion each year, while the gross annual costs accounting for long-term care and lost productivity approach $60 billion. Therefore, pediatric TBI is a major public health concern and new ways to diagnose and treat TBI are urgently needed.
Primary Outcome
Global and regional cerebral atrophy will be assessed using MRI
Interventions
- OTHER MRI Scans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2022-05 |
What the finished NCT02688660 record still lists
NCT02688660 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 82 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI Scans is the first listed.
NCT02688660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02688660 about?
NCT02688660 is a clinical study titled "MRI Markers of Outcome After Severe Pediatric TBI". Traumatic brain injury (TBI) is the leading cause of death or disability in children. Each year in the United States, pediatric TBI results in an estimated 630,000 emergency room visits, 58,900 hospitalizations, and 7000 deaths. The incidence of long-term disability after severe TBI is high, with ov...
What is the current status of trial NCT02688660?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2016-04-01. Estimated completion is 2022-05.
What interventions are being tested in trial NCT02688660?
The interventions under investigation include: MRI Scans (OTHER).
Who is sponsoring clinical trial NCT02688660?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI